Biography
Patrick Couvreur obtained his Candidature in pharmaceutical science in 1969, at the University of Namur, [3] followed by a diploma in pharmacy in 1972, at the Catholic University of Louvain (UCL). [2] He received a Doctorate in pharmaceutical science in 1975 from the same university, [2] where he worked in the laboratory next door to the Belgian Nobel Prize winner, [4] Christian de Duve, who was an inspiration for his subsequent career. [5]
From 1976 to 1977 he was a postdoctoral researcher at ETH Zurich, before joining the Catholic University of Louvain, first as a senior research assistant, and then as a senior researcher. [2]
In 1984 he was appointed to a professorship at the Institut Galien Paris Sud (University of Paris-Sud/CNRS). [6]
In 2009–2010, he held the Liliane Bettencourt Chair of Technological Innovation at the Collège de France. [7]
He has three children and several grandchildren.
Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.
The Académie des Beaux-Arts is a French learned society based in Paris. It is one of the five academies of the Institut de France. The current president of the academy (2021) is Alain-Charles Perrot, a French architect.
Nanoid robotics, or for short, nanorobotics or nanobotics, is an emerging technology field creating machines or robots, which are called nanorobots or simply nanobots, whose components are at or near the scale of a nanometer. More specifically, nanorobotics refers to the nanotechnology engineering discipline of designing and building nanorobots with devices ranging in size from 0.1 to 10 micrometres and constructed of nanoscale or molecular components. The terms nanobot, nanoid, nanite, nanomachine and nanomite have also been used to describe such devices currently under research and development.
André Bettencourt was a French politician. He had been a member of La Cagoule, a violent French fascist-leaning and anti-communist group, before and into the Second World War; he then joined the anti-German Resistance late in the war. His earlier affiliation was not known when he later served as a cabinet minister under presidents Pierre Mendès France and Charles de Gaulle, and was awarded for his bravery in the Resistance against the Nazis.
Gérard Philippe Berry is a French computer scientist, member of the French Academy of Sciences, French Academy of Technologies, and Academia Europaea. He was the Chief Scientist Officer of Esterel Technologies from 2000 to 2009. He held the 2007-2008 yearly Liliane Bettencourt chair of Technological Innovation at the Collège de France. He was Director of Research at INRIA Sophia-Antipolis and held the 2009-2010 yearly Informatics and Digital Sciences chair at the Collège de France. Berry's work, which spans over more than 30 years, brought important contributions to three main fields:
Mathias Fink, born in 1945 in Grenoble, is a French physicist, professor at ESPCI Paris and member of the French Academy of Sciences.
Pierre Potier was a French pharmacist as well as a chemist. He held the position of Director of the Institut de Chimie des Substances Naturelles, as well as a teaching position at the Muséum national d'histoire naturelle. He was a member of the Académie nationale de pharmacie, the Académie des sciences, the Académie des technologies and the Academia Europaea.
Louis Dubertret was born on 18 June 1943 in Douai, France. He had a distinctive career as an associate professor specializing in dermatology and cutaneous biology, is now a Professor Emeritus, and currently serves as the president of the René Touraine Foundation.
Vladimir Petrovich Torchilin is a Soviet, Russian and American biochemist, pharmacologist, and an expert in medical nanotechnology. Torchillin is a University Distinguished Professor of Pharmaceutical Sciences at Northeastern University. He also serves as a director at both the Center for Translational Cancer Nanomedicine and at the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University.
Paris-Saclay University is a combined technological research institute and public research university in Paris, France. Paris-Saclay was established in 2019 after the merger of four technical grandes écoles, as well as several technological institutes, engineering schools, and research facilities; giving it fifteen constituent colleges with over 48,000 students combined.
The Institute of Pharmacology and Structural Biology is a research center run as a collaboration between the French National Centre for Scientific Research and Paul Sabatier University. It has a scientific and administrative staff of 260 people, including a large number of postdoctoral workers and postgraduate students. The primary objective of the institute is the identification and characterization of novel therapeutic targets in the fields of cancer and infectious diseases.
Jackie Yi-Ru Ying is an American nanotechnology scientist based in Singapore. She is the founding executive director of the Institute of Bioengineering and Nanotechnology (IBN).
In pharmacology and medicine, vectorization of drugs refers to (intracellular) targeting with plastic, noble metal or silicon nanoparticles or liposomes to which pharmacologically active substances are reversibly bound or attached by adsorption.
María José Alonso Fernandez is a full professor of biopharmaceutics and pharmaceutical technology at the University of Santiago de Compostela. The laboratory she leads is specialized in pharmaceutical nanotechnology and nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.
Omid Farokhzad is an Iranian-American physician, scientist, and entrepreneur in the development of nanomedicines. Farokhzad is a Professor of Anesthesiology at Harvard Medical School. Omid Farokhzad is the Chair, Chief Executive Officer and co-founder for Seer, a company focused on deep, unbiased proteomics analysis at scale. The Boston Globe selected him among the top innovators in Massachusetts and the Boston Business Journal selected him among the Health Care Champions for his innovations.
Bernard Meunier is a French chemist and academic. He has been a member of the Académie des sciences since 1999.
Jean-Paul Laumond was a French robotician, research director at the CNRS, member of the French Academy of Sciences and the French Academy of Technologies.
Laurent Levy is a French physical chemist, inventor, and pioneer of nanotechnology and nanomedicine. He is the co-founder of the global biotechnology company Nanobiotix, and has served as chief executive officer (CEO) since its inception in March 2003. He also authored more than 35 international scientific publications and has applied for several patents.
M.S. Muthu is a Pharmaceutical engineer, Scientist, Inventor and one of the twenty Institute Professors at the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi, India. He is a researcher in the fields of nanomedicine, targeted drug delivery, and in theranostics nanomedicine for imaging and therapy.
Helen M. Burt is a British-Canadian pharmaceutical scientist who is the Angiotech Professor of Drug Delivery at the University of British Columbia. She serves as Associate Vice President of Research and Innovation at UBC. Her research considers novel therapeutics based on nanotechnology, including drug delivery systems for the treatment of bladder cancer and coronary artery disease.
